Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in neuroscience and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics, and is advancing research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. With approximately 9000 people worldwide, Biogen is truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to its research operations. Its international headquarters are based in Zug, Switzerland and it has world-class manufacturing facilities in Research Triangle Park, North Carolina. Biogen offers therapies to patients in 102 countries, with direct affiliate offices in 39 countries.

MCSC Industry Advisory Board (IAB) Members

Jennifer Wright

As Head of Corporate Sustainability at Biogen, Jennifer leads programs and initiatives to decarbonize Biogen’s global operations in alignment with the Science Based Targets initiative-approved climate goals. In 2020, she helped to develop and launch Biogen’s Healthy Climate, Healthy Lives initiative, a 20 year, $250M commitment to eliminate fossil fuels across the company’s operations, engage employees and suppliers, and collaborate with renowned institutions to advance the science and to improve human health outcomes. Jennifer has been working in the field of sustainability and environment health safety for over 25 years in both the environmental and pharmaceutical industries. During her 11 years at Biogen she’s held various roles including leading the EHS&S team at the corporate headquarters in Cambridge, MA and most recently, assuming responsibility for revamping and driving Biogen’s sustainability strategy.

Jennifer holds a BS in Marine Biology, a BS in Environmental Biology from the Florida Institute of Technology and a MS in Environmental Management from the University of San Francisco.

Johanna C. Jobin, MEM

As Global Head of Biogen’s Corporate Reputation and Responsibility strategy, Johanna works to enhance Biogen’s reputation as a neuroscience leader, including corporate branding, crisis and issues management and corporate responsibility across various environmental, social and governance (ESG) matters.

Leading Biogen’s Corporate Responsibility strategy, Johanna develops and implements programs across environmental, social and governance dimensions to fulfill Biogen’s mission as a responsible and purpose-driven company. Johanna maintains and strengthens Biogen’s leadership reputation– from developing strategies to enhance, build and protect Biogen’s brand and narrative to driving compelling communications and transparent reporting with key stakeholders.

She also serves as the Executive Director of the Biogen Foundation and leads Biogen’s global community engagement strategy with a strong focus on providing equitable access to inclusive science education through its long-standing Community Lab program. Twitter: @JohannaJobin.